Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome
- PMID: 14627317
- DOI: 10.1007/s00246-002-0215-3
Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome
Abstract
Thiamine-responsive megaloblastic anemia (TRMA) syndrome is a rare autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment. Other features of this syndrome gradually develop. We describe three TRMA patients with heart rhythm abnormalities and structural cardiac anomalies. Eight other reported TRMA patients also had cardiac anomalies. Recently, the TRMA gene, SLC19A2, was identified, encoding a functional thiamine transporter. Characterization of the metabolic defect of TRMA may shed light on the role of thiamine in common cardiac abnormalities.
Similar articles
-
Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.Nat Genet. 1999 Jul;22(3):300-4. doi: 10.1038/10372. Nat Genet. 1999. PMID: 10391221
-
Thiamine-responsive megaloblastic anemia syndrome (TRMA) with cone-rod dystrophy.Ophthalmic Genet. 2000 Dec;21(4):243-50. Ophthalmic Genet. 2000. PMID: 11135496
-
Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.Nat Genet. 1999 Jul;22(3):309-12. doi: 10.1038/10385. Nat Genet. 1999. PMID: 10391223
-
Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome.Diabetes Care. 1998 Jan;21(1):38-41. doi: 10.2337/diacare.21.1.38. Diabetes Care. 1998. PMID: 9538968 Review.
-
Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.Pediatr Diabetes. 2012 Jun;13(4):314-21. doi: 10.1111/j.1399-5448.2012.00855.x. Epub 2012 Feb 27. Pediatr Diabetes. 2012. PMID: 22369132 Review.
Cited by
-
Neonatal diabetes mellitus: remission induced by novel therapy.BMJ Case Rep. 2019 Jun 25;12(6):e228806. doi: 10.1136/bcr-2018-228806. BMJ Case Rep. 2019. PMID: 31243025 Free PMC article.
-
Thiamine-responsive megaloblastic anemia syndrome with Ebstein anomaly: a case report.Eur J Pediatr. 2014 Dec;173(12):1663-5. doi: 10.1007/s00431-013-2237-7. Epub 2013 Dec 20. Eur J Pediatr. 2014. PMID: 24357267
-
An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment.Ital J Pediatr. 2023 Nov 30;49(1):158. doi: 10.1186/s13052-023-01553-1. Ital J Pediatr. 2023. PMID: 38037112 Free PMC article.
-
A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives.Evid Based Complement Alternat Med. 2006 Mar;3(1):49-59. doi: 10.1093/ecam/nek009. Evid Based Complement Alternat Med. 2006. PMID: 16550223 Free PMC article.
-
Right ventricular dysfunction in thiamine-responsive megaloblastic anaemia syndrome: a case report.Heart Asia. 2011 Jan 1;3(1):140-2. doi: 10.1136/heartasia-2011-010017. eCollection 2011. Heart Asia. 2011. PMID: 27326013 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Medical